Close

Roth Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Hold. Price Target Cut

November 24, 2009 8:37 AM EST Send to a Friend
Roth Capital downgrades Alnylam Pharmaceuticals (Nasdaq: ALNY) to Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login